Gene: GAD1
Official Full Name: glutamate decarboxylase 1provided by HGNC
Gene Summary: This gene encodes one of several forms of glutamic acid decarboxylase, identified as a major autoantigen in insulin-dependent diabetes. The enzyme encoded is responsible for catalyzing the production of gamma-aminobutyric acid from L-glutamic acid. A pathogenic role for this enzyme has been identified in the human pancreas since it has been identified as an autoantigen and an autoreactive T cell target in insulin-dependent diabetes. This gene may also play a role in the stiff man syndrome. Deficiency in this enzyme has been shown to lead to pyridoxine dependency with seizures. Alternative splicing of this gene results in two products, the predominant 67-kD form and a less-frequent 25-kD form. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO06577 | GAD1 Knockout cell line (HeLa) | Human | GAD1 | 1:3~1:6 | Negative | Online Inquiry |
KO06578 | GAD1 Knockout cell line (HCT 116) | Human | GAD1 | 1:2~1:4 | Negative | Online Inquiry |
KO06579 | GAD1 Knockout cell line (HEK293) | Human | GAD1 | 1:3~1:6 | Negative | Online Inquiry |
GAD1 Gene Knockout Cell Lines represent a sophisticated tool in molecular biology, specifically tailored for studying gamma-aminobutyric acid (GABA) pathways by eliminating the GAD1 gene responsible for synthesizing glutamate decarboxylase 1. These cell lines are engineered using advanced CRISPR-Cas9 technology, which allows for precise editing within the genome, providing researchers with the ability to dissect cellular mechanisms related to neurotransmission and neurodevelopment. By creating a knockout of the GAD1 gene, these cell lines facilitate the investigation of GABA's role in various physiological processes and diseases, notably in neurological disorders such as epilepsy and anxiety.
The main function of GAD1 Gene Knockout Cell Lines lies in their ability to model conditions of impaired GABAergic signaling, thereby providing insights into the neurochemical pathways altered during disease progression. Scientists can utilize these cell lines to explore therapeutic strategies, test drug responses, and analyze compensatory mechanisms that arise in response to GAD1 suppression. Their application extends into basic research, drug discovery, and translational studies aimed at understanding the neurobiological aspects of mental health disorders.
One key advantage of GAD1 Gene Knockout Cell Lines over traditional methods, such as pharmacological inhibition or transient expression systems, is their ability to offer a stable genetic background for reproducibility in experiments. Additionally, these cell lines allow for nuanced studies of the GABAergic system without the confounding effects of compensatory gene expression often seen with less precise gene manipulation techniques.
For researchers and clinicians alike, the GAD1 Gene Knockout Cell Lines provide invaluable resources for advancing knowledge in neurobiology and developing targeted therapies. Their robust design and specificity ensure that users can derive reliable and relevant data to support their research objectives.
Our company is dedicated to delivering cutting-edge biological products that empower researchers to make significant advancements in their fields. With a focus on high-quality genetic tools, we are committed to supporting your scientific endeavors with exceptional resources that meet the evolving demands of modern research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.